- Home
- Publications
- Publication Search
- Publication Details
Title
Roles of mTOR in Diabetic Kidney Disease
Authors
Keywords
-
Journal
Antioxidants
Volume 10, Issue 2, Pages 321
Publisher
MDPI AG
Online
2021-02-23
DOI
10.3390/antiox10020321
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition
- (2020) Issei Tomita et al. Cell Metabolism
- Proximal Tubule mTORC1 Is a Central Player in the Pathophysiology of Diabetic Nephropathy and Its Correction by SGLT2 Inhibitors
- (2020) Aviram Kogot-Levin et al. Cell Reports
- Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ Transplantation
- (2019) Lee S. Nguyen et al. DRUG SAFETY
- Rapamycin improves insulin resistance and hepatic steatosis in type 2 diabetes rats through activation of autophagy
- (2018) Wan Zhou et al. CELL BIOLOGY INTERNATIONAL
- A Low-Protein Diet for Diabetic Kidney Disease: Its Effect and Molecular Mechanism, an Approach from Animal Studies
- (2018) Munehiro Kitada et al. Nutrients
- mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3
- (2018) Guoli Shi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Secular changes in clinical manifestations of kidney disease among Japanese adults with type 2 diabetes from 1996 to 2014
- (2018) Shinji Kume et al. Journal of Diabetes Investigation
- The Complex Roles of Mechanistic Target of Rapamycin in Adipocytes and Beyond
- (2017) Peter L. Lee et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- mTORC1 signaling in hepatic lipid metabolism
- (2017) Jinbo Han et al. Protein & Cell
- Rapamycin treatment benefits glucose metabolism in mouse models of type 2 diabetes
- (2016) Peter C. Reifsnyder et al. Aging-US
- Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014
- (2016) Maryam Afkarian et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- mTOR Regulates Endocytosis and Nutrient Transport in Proximal Tubular Cells
- (2016) Florian Grahammer et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- MicroRNA148b-3p inhibits mTORC1-dependent apoptosis in diabetes by repressing TNFR2 in proximal tubular cells
- (2016) Shogo Kuwagata et al. KIDNEY INTERNATIONAL
- An endoplasmic reticulum stress-regulated lncRNA hosting a microRNA megacluster induces early features of diabetic nephropathy
- (2016) Mitsuo Kato et al. Nature Communications
- Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy
- (2015) Atsuko Tagawa et al. DIABETES
- Updating the natural history of diabetic nephropathy
- (2014) Giuseppe Pugliese ACTA DIABETOLOGICA
- Risk of Metabolic Complications in Kidney Transplantation After Conversion to mTOR Inhibitor: A Systematic Review and Meta-Analysis
- (2014) N. Murakami et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Molecular mechanisms of diabetic kidney disease
- (2014) Kimberly Reidy et al. JOURNAL OF CLINICAL INVESTIGATION
- A Central Role for mTOR in Lipid Homeostasis
- (2013) Dudley W. Lamming et al. Cell Metabolism
- Evidence for Rapamycin Toxicity in Pancreatic β-Cells and a Review of the Underlying Molecular Mechanisms
- (2013) Adam D. Barlow et al. DIABETES
- Obesity-Mediated Autophagy Insufficiency Exacerbates Proteinuria-induced Tubulointerstitial Lesions
- (2013) K. Yamahara et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- AKT2 is essential to maintain podocyte viability and function during chronic kidney disease
- (2013) Guillaume Canaud et al. NATURE MEDICINE
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- New targets for treatment of diabetic nephropathy
- (2012) Frank C. Brosius et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Rapamycin toxicity in MIN6 cells and rat and human islets is mediated by the inhibition of mTOR complex 2 (mTORC2)
- (2012) A. D. Barlow et al. DIABETOLOGIA
- Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice
- (2012) T. Kuwabara et al. DIABETOLOGIA
- Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
- (2012) D. W. Lamming et al. SCIENCE
- Mitochondria removal by autophagy
- (2011) Ke Wang et al. Autophagy
- Resveratrol Improves Oxidative Stress and Protects Against Diabetic Nephropathy Through Normalization of Mn-SOD Dysfunction in AMPK/SIRT1-Independent Pathway
- (2011) M. Kitada et al. DIABETES
- Nutrient Sensing, Autophagy, and Diabetic Nephropathy
- (2011) S. Kume et al. DIABETES
- Transcriptome Analysis of Human Diabetic Kidney Disease
- (2011) K. I. Woroniecka et al. DIABETES
- Role of mTOR in podocyte function and diabetic nephropathy in humans and mice
- (2011) Markus Gödel et al. JOURNAL OF CLINICAL INVESTIGATION
- mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice
- (2011) Ken Inoki et al. JOURNAL OF CLINICAL INVESTIGATION
- Fenofibrate, a PPARα agonist, has renoprotective effects in mice by enhancing renal lipolysis
- (2011) Yuki Tanaka et al. KIDNEY INTERNATIONAL
- Network organization of the human autophagy system
- (2010) Christian Behrends et al. NATURE
- The RAAS in the pathogenesis and treatment of diabetic nephropathy
- (2010) Piero Ruggenenti et al. Nature Reviews Nephrology
- The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential
- (2009) Hiroyuki Mori et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started